Jennifer king

---

Jennifer King is a Partner at Value Genome.  She brings a wealth of commercial and access experience across oncology and orphan drugs.  She has worked in Global, EMEA and Asia Pacific/Japan markets in Pricing & Market Access.  She plays an active role in advising clients on pricing and market access strategies with the goal of achieving optimal access for all stakeholders.  Her extensive industry experience across therapeutic areas and geographies ensures clients benefits from that knowledge in both strategic development and implementation.

In her last position, Jennifer was Head of Pricing & Market Access at Celgene where she led the successful reimbursement of all Celgene products in the Asia Pacific Region including Japan.  She also led the Global launch of Abraxane in mBC and NSCLC as the Head of Market Access for Solid Tumor.  Jennifer has over 20 years of pricing and market access experience and worked for Amgen, Pfizer and Merck prior to Celgene.

Jennifer has a B.A. in Biochemistry from University of California, Berkeley and a MBA from Lehigh University.